Association between the HLA-G molecule and lymph node metastasis in papillary thyroid cancer

Human Immunology

Volumn 74, Issue 4, 2013, Pages 447-451

  Nunes, Larissa Mesquita ^a   Ayres, Flávio Monteiro ^b   Francescantonio, Isadora Carvalho Medeiros ^a   Saddi, Vera Aparecida ^a   Avelino, Melissa Ameloti Gomes ^a   Alencar, Rita de Cássia Gonçalves ^c   Silva, Rosana Correa da ^c   Meneghini, Alexandre J ^c   Wastowski, Isabela Jubé ^b  

^a PONTIFÍCIA UNIVERSIDADE CATÓLICA DE GOIÁS   (Brazil)

^b UNIVERSIDADE ESTADUAL DE GOIÁS   (Brazil)

^c Hospital Araujo Jorge   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN;

ADULT; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CANCER; THYROID CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARCINOMA; FEMALE; GENE EXPRESSION; HLA-G ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; THYROID GLAND; THYROID NEOPLASMS;

EID: 84875081301     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.12.012     Document Type: Article

References (22)

1. Camboim D.C., Figueirôa V.M.S.M., Lima D.M.O., Lima P.A., Lima C.C. Carcinoma papilífero da tireoide associado à tireoidite de Hashimoto: frequência e aspectos histopatológicos. J Bras Patol 2009, 45(1):75-82.
2. Romagnoli S., Moretti S., Voce P., Puxeddu E. Terapias moleculares direcionadas em câncer de tireoide. Arq Bras Endocrinol Metab 2009, 53(9):1061-1073.
3. Cooper D.S., Doherty G.M., Haugen B.R., Kloos R.T., Lee S.L., Mandel S.J. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006, 16:109-142.
4. Srinivas P.R., Kramer B.S., Srivastava S. Trends in biomarker research for cancer detection. Lancet Oncol 2001, 2:698-704.
5. Carosella E.D., Horuzsko A. HLA-G and cancer. Semin Cancer Biol 2007, 17(6):411-412.
6. Rouas-Freiss N., Moreau P., Ferrone S., Carosella E.D. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?. Cancer Res 2005, 65(22):101-139.
7. Rouas-Freiss N., Khalil-Daher I., Menier C., Paul P., Dausset J., Carosella E.D. The immunotolerance role of HLA-G. Semin Cancer Biol 1999, 9:3-12.
8. Paul P., Rouas-Freiss N., Khalil-Daher I., Moreau P., Riteau B., Le Gal F.A., et al. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci 1998, 95:4510-4515.
9. Davies B., Hiby S., Gardner L., Loke Y.W., King A. HLA-G expression by tumors. Am J Reprod Immunol 2001, 45:103-107.
10. Kleinberg L., Florenes V.A., Skrede M., Dong H.P., Nielsen S., McMaster M.T., Shih Ie M., Davidson B., et al. Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma. Virchows Arch 2006, 449(1):31-39.
11. Hansel D.E., Rahman A., Wilentz R.E., Shih Ie M., McMaster M.T., Yeo C.J., Maitra A. HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract. Int J Gastrointest Cancer 2005, 35(1):15-23.
12. Singer G., Kurman R.J., McMaster M., Shih I.-M. HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am J Surg Pathol 2002, 26(7):914-920.
13. Singer G., Rebmann V., Chen Y.C., Liu H.T., Ali S.Z., Reinsberg J., Shih Ie M., et al. HLA-G is a potential tumor marker in malignant ascites. Clin Cancer Res 2003, 9(12):4460-4464.
14. Bukur J., Rebmann V., Grosse-Wilde H., Luboldt H., Ruebben H., Drexler I., et al. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma. Cancer Res 2003, 63(14):4107-4111.
15. Urosevic M., Kurrer M.O., Kamarashev J., Mueller B., Weder W., Burg G., et al. Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol 2001, 159(3):817-824.
16. Shih I.M. Application of HLA-G expression in the diagnosis of human cancer. Hum Immunol 2007, 68(4):272-276.
17. Edge S.B., Byrd D.R., Compton C.C., Fritz A.G., Greene F.L., Trotti A. AJCC cancer staging manual 2010, Springer-Verlag, New York, NY. 7th ed.
18. Lefebvre S., Antoine M., Uzan S., McMaster M., Dausset J., Carosella E.D., et al. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast. J Pathol 2002, 196:266-274.
19. Caumartin J., Favier B., Daouya M., Guillard C., Moreau P., Carosella E.D., et al. Trogocytosis - based generation of suppressive NK cells. EMBO J 2007, 26:1423-1433.
20. Kemp E.H., Metcalfe R.A., Watson P.F., Weetman A.P. HLA-G does not have a pathophysiological role in Graves' disease. J Clin Pathol 2003, 56:475-477.
21. Ito Y., Jikuzono T., Higashiyama T., Asahi S., Tomoda C., Takamura Y., et al. Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg 2006, 30(10):1821-1828.
22. Sakorafas G.H., Sampanis D., Safioleas M. Cervical lymphnode dissection in papillary thyroid cancer: current trends, persisting controversies, and unclarified uncertainties. Surg Oncol 2010, 19(2):57-70.